SEC Form 4 · accession 0001144204-15-060242
China Biologic Products, Inc. · CBPO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Gao
Officer — Chief Executive Officer · Director
Period of report
Oct 19, 2015
Accepted (ET)
Oct 21, 2015 · 4:31 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001369868
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Oct 19, 2015 | S | 200 | $105.025 | D | 616,800 | D | |
| Common StockF1 | Oct 20, 2015 | S | 258 | $105.00 | D | 616,542 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents 458 shares of common stock sold through a trading plan (the "10b5-1 Plan") adopted by the Reporting Person on September 14, 2015 that complies with the requirements of Rule 10b5-1(c)(1) under the Securities Exchange Act of 1934, as amended. The Reporting Person intends to use the proceeds from the sales effected under the 10b5-1 Plan to pay income tax due in connection with the scheduled vesting of certain restricted stock held by the Reporting Person and the exercise of certain stock options held by the Reporting Person.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in the open market at prices ranging from $105.020 to $105.030, inclusive. The Reporting Person undertakes to provide to any security holders of the Issuer or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this Footnote 2.